Enlivex rStock RENLV
RENLV
0
$
0.00 %
Change 24h
Market Cap
$ 0
RENLV
$
| # | Exchange | Pair | Price | Volume 24h |
|---|
Description
Enlivex Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing immunomodulatory therapies. Utilizing its proprietary macrophage reprogramming technology platform, the company researches innovative treatments for sepsis, solid tumors, and autoimmune diseases.